Year-End Report — ARENTFOX SCHIFF LLP for HEMATECH INC (2007)

Firm

ARENTFOX SCHIFF LLP

Client

HEMATECH INC

Income

$20,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY '09 Department of Defense appropriations regarding advanced therapeutic development for bioterrorism response

Lobbyist	Covered position, as disclosed
MATTHEW JOSEPH KEELEY	N/A
MARGO KLOSTERMAN	N/A
RACHEL G LATTIMORE	N/A
DAN RENBERG	N/A

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Funding for development of medical therapeutics for bioterrorism response

Lobbyist	Covered position, as disclosed
MATTHEW JOSEPH KEELEY	N/A
MARGO KLOSTERMAN	N/A
RACHEL G LATTIMORE	N/A
DAN RENBERG	N/A

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.